VAFSEO

This brand name is authorized in Austria, Estonia, Ireland, Italy, Japan, Lithuania

Active ingredients

The drug VAFSEO contains one active pharmaceutical ingredient (API):

1 Vadadustat UNII I60W9520VV - VADADUSTAT

Vadadustat is a hypoxia-inducible factor prolyl-hydroxylase inhibitor which leads to increased cellular levels of hypoxia-inducible factor thereby stimulating endogenous erythropoietin (EPO) production, increasing iron mobilization and red blood cell production, resulting in gradual rate of rise in Hb. Read about Vadadustat

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VAFSEO Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03XA08		B Blood and blood forming organs → B03 Antianemic preparations → B03X Other antianemic preparations → B03XA Other antianemic preparations
Discover more medicines within B03XA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 3037081, 3037092, 3037104, 3037115, 3037126, 3037137
Country: IT	Agenzia del Farmaco	Identifier(s): 050660012, 050660024, 050660036, 050660048, 050660051, 050660063
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999050F1020, 3999050F2026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1097020, 1097021, 1097022, 1097023, 1097024, 1097025